Version 1
: Received: 12 April 2024 / Approved: 15 April 2024 / Online: 15 April 2024 (11:57:23 CEST)
How to cite:
Silva, R. J. D.; Júnior, C. R. D. S.; Abreu, T.; Minussi, C. R.; Lopes, M. L. M. Machine Learning for Affordable Diagnosis of SARS-COV-2 from Hematological and Biochemical Tests. Preprints2024, 2024040956. https://doi.org/10.20944/preprints202404.0956.v1
Silva, R. J. D.; Júnior, C. R. D. S.; Abreu, T.; Minussi, C. R.; Lopes, M. L. M. Machine Learning for Affordable Diagnosis of SARS-COV-2 from Hematological and Biochemical Tests. Preprints 2024, 2024040956. https://doi.org/10.20944/preprints202404.0956.v1
Silva, R. J. D.; Júnior, C. R. D. S.; Abreu, T.; Minussi, C. R.; Lopes, M. L. M. Machine Learning for Affordable Diagnosis of SARS-COV-2 from Hematological and Biochemical Tests. Preprints2024, 2024040956. https://doi.org/10.20944/preprints202404.0956.v1
APA Style
Silva, R. J. D., Júnior, C. R. D. S., Abreu, T., Minussi, C. R., & Lopes, M. L. M. (2024). Machine Learning for Affordable Diagnosis of SARS-COV-2 from Hematological and Biochemical Tests. Preprints. https://doi.org/10.20944/preprints202404.0956.v1
Chicago/Turabian Style
Silva, R. J. D., Carlos Roberto Minussi and Mara Lúcia Martins Lopes. 2024 "Machine Learning for Affordable Diagnosis of SARS-COV-2 from Hematological and Biochemical Tests" Preprints. https://doi.org/10.20944/preprints202404.0956.v1
Abstract
COVID-19, caused by the SARS-CoV-2 virus, has spread around the world and killed around 6.9 million people. Rapid and accurate diagnosis is essential for preventing and controlling the disease, reducing transmission and consequently saving lives. RT-PCR is the gold standard test used to detect the disease. However, the test is expensive and the result is time-consuming, which makes mass testing difficult, especially in countries with limited resources. In addition, the test has high analytical specificity and low diagnostic sensitivity, which leads to false-negative results. Several studies in the literature report the presence of hematological and biochemical alterations in infected patients and use these alterations with machine learning algorithms to help diagnose the disease. Therefore, this article presents the results obtained by different neural network architectures based on Adaptive Resonance Theory (ART) for the diagnosis of COVID-19. The study was conducted in two distinct stages: the first consisted of selecting the best ART network among several, using three open-access datasets and comparing the results with the literature. In the second stage, the chosen model was tested on a dataset containing patients from various hospitals in four countries. In addition, the model was subjected to external validation, including data from a country not present during the training and adjustment of the model, in order to validate the robustness and generalization capacity of the model. The results obtained by the ART networks in this study are promising, outperforming not only classical models, but also the deep learning models often used in the literature. Validation on data from different countries strengthens the model’s reliability and effectiveness.
Engineering, Electrical and Electronic Engineering
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.